ACTIVE

UROLOGIE KEMPEN

Financial year 2025 · Closed on 31/12/2025

Net result-394,8 €-9,1 %over 1 year
Gross margin1,4 k €+217,5 %over 1 year
Equity8,2 k €-4,6 %over 1 year

Identity

Source · BCE/KBO

UROLOGIE KEMPEN is a Private limited company incorporated in 2022. Its main activity is: Specialist medical practice activities. Its registered office is in Herentals.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0785.557.270
Incorporation
29/04/2022
Legal form
Private limited company
Registered office
Nederrij(HRT) 133
2200 Herentals · FlandreSee on map
Contributed capital
11 000,00 €
Latest accounts
31/12/2025
Signals
Good liquidityPositive EBITDA

Financials

Source · NBB, 4 filings

Trend over 4 financial years

2025202420232022
Income statement
Gross margin1,4 k €449,6 €596,1 €-72,6 €
EBITDA53 €43,5 €39 €-1,3 k €
Operating result53 €43,5 €39 €-1,3 k €
Net result-394,8 €-362 €-52,7 €-2 k €
Balance sheet
Equity8,2 k €8,6 k €9 k €9 k €
Total assets1,2 M €1,1 M €1,1 M €814 k €
Cash240,2 k €229,7 k €266,6 k €2,2 k €
Debts290,8 k €183,1 k €155,1 k €127,9 k €

Valuation

Indicative valuation

As an indication, this company is worth

between 100 k€ and 250 k€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

10 active · 29 ended

Active mandates

DH Urologie

Director · 0675.633.209

Represented by Philippus den Hollander

Active
Dr. CS & Dr. PVA

Director · 0761.596.686

Represented by Charlotte Schillebeeckx

Active
Dr. Eline Peeters, urologie

Director · 0774.357.136

Represented by Eline Peeters

Active
DR. SCHURMANS J. UROLOGIE

Director · 0559.815.011

Represented by Johan Schurmans

Active
DR. VAN REUSEL- DR. MICHELS

Director · 0891.156.024

Represented by Raf Van Reusel

Active
MICRUROL

Director · 0818.627.342

Represented by Kristof Durt

Active
NOFLO

Director · 0694.921.064

Represented by Siebe van den Bouwhuijsen

Active
ROLEF

Director · 1010.581.434

Represented by Thomas Roza

Active
Uro-Lógica

Director · 0778.827.351

Represented by Sofie Stuyck

Active
Urologie Dr. P. Janssen

Director · 1000.522.039

Represented by Pieter Jan Janssen

Active

Ended mandates

Urologie Dr. P. Janssen

Director · since 28 novembre 2023 · until 28 avril 2025 · 1000.522.039

Represented by Pieter Janssen

Ended
Urologie Dr. P. Janssen

Director · since 28 novembre 2023 · 1000.522.039

Represented by Janssen PIETER JAN

Ended
DH Urologie

Director · since 28 avril 2022 · 0675.633.209

Represented by den HOLLANDER PHILIPPUS

Ended
DH Urologie

Director · since 28 avril 2022 · until 28 avril 2025 · 0675.633.209

Represented by Philippus den Hollander

Ended

Other companies at this address

Nederrij(HRT) 133 2200 Herentals
CompanyCBE no.
0782.315.391
0659.665.227
0821.734.213
0786.287.839
0656.748.891
0811.149.731
TO WALK AGAIN● Active
0862.179.352
0669.498.453

Full financial information

Source · NBB
2025202420232022
Type of accountAbridged modelAbridged modelAbridged modelMicro model
Start of the financial year01/01/202501/01/202401/01/202328/04/2022
Closing of the financial year31/12/202531/12/202431/12/202331/12/2022
Length of the financial year12 months12 months12 months9 months
Filing date30/07/202623/07/202525/07/202430/07/2023
General meeting26/06/202627/06/202528/06/202430/06/2023
Currency of the financial yearEUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 4 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202526/06/202630/07/2026DutchPDF
Abridged model31/12/202427/06/202523/07/2025DutchPDF
Abridged model31/12/202328/06/202425/07/2024DutchPDF
Micro model31/12/202230/06/202330/07/2023DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 100 k€ and 250 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

10 active · 29 ended

Active mandates

DH Urologie

Director · 0675.633.209

Represented by Philippus den Hollander

Active
Dr. CS & Dr. PVA

Director · 0761.596.686

Represented by Charlotte Schillebeeckx

Active
Dr. Eline Peeters, urologie

Director · 0774.357.136

Represented by Eline Peeters

Active
DR. SCHURMANS J. UROLOGIE

Director · 0559.815.011

Represented by Johan Schurmans

Active
DR. VAN REUSEL- DR. MICHELS

Director · 0891.156.024

Represented by Raf Van Reusel

Active
MICRUROL

Director · 0818.627.342

Represented by Kristof Durt

Active
NOFLO

Director · 0694.921.064

Represented by Siebe van den Bouwhuijsen

Active
ROLEF

Director · 1010.581.434

Represented by Thomas Roza

Active
Uro-Lógica

Director · 0778.827.351

Represented by Sofie Stuyck

Active
Urologie Dr. P. Janssen

Director · 1000.522.039

Represented by Pieter Jan Janssen

Active

Ended mandates

Urologie Dr. P. Janssen

Director · since 28 novembre 2023 · until 28 avril 2025 · 1000.522.039

Represented by Pieter Janssen

Ended
Urologie Dr. P. Janssen

Director · since 28 novembre 2023 · 1000.522.039

Represented by Janssen PIETER JAN

Ended
DH Urologie

Director · since 28 avril 2022 · 0675.633.209

Represented by den HOLLANDER PHILIPPUS

Ended
DH Urologie

Director · since 28 avril 2022 · until 28 avril 2025 · 0675.633.209

Represented by Philippus den Hollander

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates29/07/2025
    ONTSLAG - BENOEMING ;
    PDF
  • Mandates25/03/2024
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates29/08/2023
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Other03/05/2022
    RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025-394,8 €↓
  2. 2024
    Annual accounts 2024-362 €↓
  3. 2023
    Annual accounts 2023-52,7 €↑
  4. 2022
    Annual accounts 2022-2 k €
  5. 29/04/2022
    IncorporationPrivate limited company